-
-
-
-
-
-
-
Kintara Therapeutics Announces Correction to Prior Announcement Regarding CVR Issuance in Connection with the Proposed Merger with TuHURA Biosciences Expected to Close on October 18, 2024
-
-
-
-
-
-
-
Kintara Therapeutics Provides Update on Corporate Developments and REM-001 Clinical Study
-
-
-
-
-
-
-
TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.’s KVA12123 Novel anti-VISTA Checkpoint Inhibitor
-
-
-
-
-
-
-
TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcin
-
-
-
-
-
-
-
Kintara Therapeutics (KTRA) Reports Q2 EPS of ($0.12), $14M Cash on Hand, Issues Business Update
-
-
-
-
-
-
-
Pre-Open Stock Movers 07/01: (CPOP) (KTRA) (FC) Higher; (CVAC) (MKSI) (ATC) Lower (more...)
-
-
-
-
-
-
-
Proactive news headlines including Esports Entertainment Group, Unigold, ElectraMeccanica Vehicles Corp and Bam Bam Resources
-
1,160,189 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

